V. Navarro Compán - LUMC | 人才画像

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 135 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

AB0945 THE IMPACT OF AXIAL SPONDYLOARTHRITIS ON PATIENTS’ SEXUAL LIFE. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)

Garrido-Cumbrera M.,Poddubnyy D.,Sommerfleck F.,Bundy C.,Makri S.,Correa-Fernández J.,Akerkar S.M.,Lowe J.,Karam E.,Navarro-Compán V.

Annals of the Rheumatic Diseases (2024): 1784

引用0浏览0引用

POS0194 FACTORS ASSOCIATED WITH RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING IL-17A INHIBITOR OR TNF INHIBITOR THERAPY: A POST-HOC ANALYSIS OF THE SURPASS STUDY

Poddubnyy D., Braun J.,Machado P.,Navarro-Compán V.,Gensler L.S.,Hermann K.G., Quebe-Fehling E., Pieterse C.C.,Readie A.,Gaillez C.,Baraliakos X.

Annals of the Rheumatic Diseases (2024): 346

引用0浏览0引用

BASELINE CHARACTERISTICS AND DISEASE BURDEN IN PATIENTS WITH RADIOGRAPHIC AXSPA (R-AXSPA) STRATIFIED BY CRP LEVEL: AN ANALYSIS FROM THE IXEKIZUMAB COAST-V TRIAL

R. Sengupta,P. M. Machado,P. Goupille,V Navarro Compan, X. Huji, M. Sheesh, Jing K. Ng, M. Ngantcha, H. Russ,G. Doridot,X. Baraliakos

CLINICAL AND EXPERIMENTAL RHEUMATOLOGYno. 9 (2024): 97-97

引用0浏览0引用

Le Traitement Par Bimekizumab a Été Efficace À 2 Ans, Quelle Que Soit La Durée Des Symptômes De L’axspa : Résultats De Deux Essais De Phase III

S. Ramiro,F. Proft,R. Sengupta,A. Van Tubergen,A. Molto,L.S. Gensler,M. Kishimoto,V. Taieb, D. Voiniciuc,U. Massow,V. Navarro-Compán

Revue du Rhumatisme (2024): A206-A208

引用0浏览0引用

BASDAI AND ASDAS DISEASE STATES IN RELATIONSHIP TO ASAS40 RESPONSE: POST HOC ANALYSIS FROM THE IXEKIZUMAB COAST-V STUDY IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

M. Rudwaleit,V Navarro-Compan, H. Russ,T. Panni, E. Filippi, Haschemi M. Nassab,S. Liu-Leage, V Goeb,F. Ciccia, J. Dudler

CLINICAL AND EXPERIMENTAL RHEUMATOLOGYno. 9 (2024): 86-87

引用0浏览0引用

POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION

Deodhar A.,Navarro-Compán V.,Poddubnyy D.,Gensler L.S.,Ramiro S.,Tomita T.,Marzo-Ortega H.,Fleurinck C.,Vaux T.,Massow U.,Van der Heijde D.,Baraliakos X.

Annals of the Rheumatic Diseases (2024): 349-350

引用0浏览0引用

EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS WITH SHORTER VERSUS LONGER SYMPTOM DURATION: 1-YEAR RESULTS FROM TWO PHASE 3 STUDIES

S. Ramiro,F. Proft,R. Sengupta,A. van Tubergen,A. Molto,L. S. Gensler,M. Kishimoto,V Taieb, D. Voiniciuc,C. Fleurinck,U. Massow,N. de Peyrecave,V Navarro-Compan

SWISS MEDICAL WEEKLY（2024）

引用0浏览0引用

EE329 Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against Il-23 Targeted Therapies for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons

J. Mestre-Ferrandiz,V. Navarro-Compán, Y Ivanova, A. González-Domínguez, S Maratia

Value in Healthno. 12 (2024): S119

引用0浏览0引用

PSYCHOMETRIC PROPERTIES AND THRESHOLDS TO GUIDE INTERPRETATIONS OF BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX FATIGUE QUESTION 1 (BASDAI-Q1) AND FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATIGUE (FACITFATIGUE) SUBSCALE IN AXIAL SPONDYLOARTHRITIS (AXSPA)

C. de la Loge,F. Fofana, D. Voiniciuc,V Taieb,C. Fleurinck,U. Massow,M. Dougados,V Navarro-Compan,J. A. Walsh

CLINICAL AND EXPERIMENTAL RHEUMATOLOGYno. 9 (2024): 28-29

引用0浏览0引用

AB0958 HOW ARE PATIENT REPORTED OUTCOME MEASUREMENTS USED IN AXIAL SPONDYLOARTHRITIS? A QUALITATIVE STUDY WITH HEALTH CARE PROFESSIONALS AND PATIENTS

Juanola-Roura X.,Navarro-Compán V.,Moltó A.,Oton T., Carmona L.

Annals of the Rheumatic Diseases (2024): 1792-1793

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn